PL2958624T3 - Leczenie choroby przeszczep przeciwko gospodarzowi u pacjentów z przeszczepem - Google Patents
Leczenie choroby przeszczep przeciwko gospodarzowi u pacjentów z przeszczepemInfo
- Publication number
- PL2958624T3 PL2958624T3 PL14708330T PL14708330T PL2958624T3 PL 2958624 T3 PL2958624 T3 PL 2958624T3 PL 14708330 T PL14708330 T PL 14708330T PL 14708330 T PL14708330 T PL 14708330T PL 2958624 T3 PL2958624 T3 PL 2958624T3
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- host disease
- versus host
- graft versus
- transplant patients
- Prior art date
Links
- 208000009329 Graft vs Host Disease Diseases 0.000 title 1
- 208000024908 graft versus host disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01B—SOIL WORKING IN AGRICULTURE OR FORESTRY; PARTS, DETAILS, OR ACCESSORIES OF AGRICULTURAL MACHINES OR IMPLEMENTS, IN GENERAL
- A01B1/00—Hand tools
- A01B1/02—Spades; Shovels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/664—Amides of phosphorus acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/31—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/32—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/094—Esters of phosphoric acids with arylalkanols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Soil Sciences (AREA)
- Mechanical Engineering (AREA)
- Environmental Sciences (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Inorganic Chemistry (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361766830P | 2013-02-20 | 2013-02-20 | |
| PCT/IB2014/059067 WO2014128611A1 (en) | 2013-02-20 | 2014-02-18 | Treatment of graft versus host disease in transplant patients |
| EP14708330.7A EP2958624B1 (en) | 2013-02-20 | 2014-02-18 | Treatment of graft versus host disease in transplant patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2958624T3 true PL2958624T3 (pl) | 2021-10-04 |
Family
ID=50236228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14708330T PL2958624T3 (pl) | 2013-02-20 | 2014-02-18 | Leczenie choroby przeszczep przeciwko gospodarzowi u pacjentów z przeszczepem |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20160000811A1 (pt-PT) |
| EP (1) | EP2958624B1 (pt-PT) |
| JP (2) | JP6441822B2 (pt-PT) |
| KR (1) | KR102165514B1 (pt-PT) |
| CN (1) | CN105007981B (pt-PT) |
| AU (1) | AU2014220377B2 (pt-PT) |
| BR (1) | BR112015019197A2 (pt-PT) |
| CA (1) | CA2898565C (pt-PT) |
| CY (1) | CY1124191T1 (pt-PT) |
| DK (1) | DK2958624T3 (pt-PT) |
| EA (1) | EA030783B1 (pt-PT) |
| ES (1) | ES2873181T3 (pt-PT) |
| HR (1) | HRP20210891T1 (pt-PT) |
| HU (1) | HUE054330T2 (pt-PT) |
| LT (1) | LT2958624T (pt-PT) |
| MX (1) | MX369631B (pt-PT) |
| PL (1) | PL2958624T3 (pt-PT) |
| PT (1) | PT2958624T (pt-PT) |
| RS (1) | RS61933B1 (pt-PT) |
| SI (1) | SI2958624T1 (pt-PT) |
| TW (1) | TWI648050B (pt-PT) |
| WO (1) | WO2014128611A1 (pt-PT) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108778310B (zh) * | 2016-03-08 | 2022-08-19 | 普莱欧塞拉有限公司 | 造血干细胞移植患者的处理 |
| EP3831370A4 (en) * | 2018-07-27 | 2022-04-27 | Priothera Limited | AGENT FOR INHIBITING THE RECURRENCE OF HEMATOLOGICAL MALIGNITY IN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION |
| WO2022162409A1 (en) | 2021-01-28 | 2022-08-04 | Priothera Sas | Methods of treatment with s1p receptor modulators |
| TW202245741A (zh) | 2021-01-28 | 2022-12-01 | 法商普萊歐塞拉公司 | 使用s1p受體調節劑之治療方法 |
| TW202341971A (zh) | 2022-02-16 | 2023-11-01 | 法商普萊歐塞拉公司 | 使用car細胞及s1p受體調節劑之治療方法 |
| EP4282407A1 (en) | 2022-05-27 | 2023-11-29 | Priothera SAS | Treatment of cancer with s1p receptor agonists |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998020932A2 (en) * | 1996-11-15 | 1998-05-22 | Baxter International Inc. | Conditioning for allogeneic stem cell transplantation |
| JPH11343242A (ja) * | 1998-03-30 | 1999-12-14 | Otsuka Pharmaceut Co Ltd | 造血幹細胞移植用剤 |
| US6383481B1 (en) | 1998-03-30 | 2002-05-07 | Japan Immunoresearch Laboratories Co., Ltd. | Method for transplantation of hemopoietic stem cells |
| DK1431284T3 (da) * | 2001-09-27 | 2008-02-18 | Kyorin Seiyaku Kk | Diarylsulfidderivat, additionssalt deraf samt immunundertrykkende middel |
| JP4571497B2 (ja) * | 2002-09-19 | 2010-10-27 | 杏林製薬株式会社 | アミノアルコール誘導体とその付加塩及び免疫抑制剤 |
| BRPI0513110A (pt) | 2004-07-16 | 2008-04-29 | Kyorin Seiyaku Kk | medicamento compreendendo composto sulfeto diaril ou composto éter diaril tendo uma estrutura 2-amina-1, 3-propanediol tendo uma atividade de redução de linfócitos perifericamente circulante, em combinação com um agente imunosupressivo e/ou um agente antiinflamatório e método de expressão de prevenção do efeito secundário |
| WO2006073126A1 (ja) * | 2005-01-06 | 2006-07-13 | Kissei Pharmaceutical Co., Ltd. | 慢性移植片対宿主症におけるドライアイの予防および治療剤 |
| EP2566954B2 (en) | 2010-05-04 | 2022-11-02 | Yeda Research and Development Co. Ltd. | Immunotherapy using redirected allogeneic cells |
| WO2011138398A1 (en) | 2010-05-06 | 2011-11-10 | Novartis Ag | Dosage regimen of diaryl sulfide derivatives |
-
2014
- 2014-02-18 LT LTEP14708330.7T patent/LT2958624T/lt unknown
- 2014-02-18 WO PCT/IB2014/059067 patent/WO2014128611A1/en active Application Filing
- 2014-02-18 RS RS20210626A patent/RS61933B1/sr unknown
- 2014-02-18 ES ES14708330T patent/ES2873181T3/es active Active
- 2014-02-18 KR KR1020157022190A patent/KR102165514B1/ko active IP Right Grant
- 2014-02-18 AU AU2014220377A patent/AU2014220377B2/en active Active
- 2014-02-18 EA EA201591522A patent/EA030783B1/ru not_active IP Right Cessation
- 2014-02-18 JP JP2015558580A patent/JP6441822B2/ja active Active
- 2014-02-18 HU HUE14708330A patent/HUE054330T2/hu unknown
- 2014-02-18 EP EP14708330.7A patent/EP2958624B1/en active Active
- 2014-02-18 PT PT147083307T patent/PT2958624T/pt unknown
- 2014-02-18 DK DK14708330.7T patent/DK2958624T3/da active
- 2014-02-18 BR BR112015019197A patent/BR112015019197A2/pt not_active Application Discontinuation
- 2014-02-18 PL PL14708330T patent/PL2958624T3/pl unknown
- 2014-02-18 SI SI201431824T patent/SI2958624T1/sl unknown
- 2014-02-18 CA CA2898565A patent/CA2898565C/en active Active
- 2014-02-18 CN CN201480009413.4A patent/CN105007981B/zh active Active
- 2014-02-18 US US14/768,744 patent/US20160000811A1/en not_active Abandoned
- 2014-02-18 MX MX2015010833A patent/MX369631B/es active IP Right Grant
- 2014-02-19 TW TW103105523A patent/TWI648050B/zh active
-
2018
- 2018-01-29 US US15/882,392 patent/US11224604B2/en active Active
- 2018-11-22 JP JP2018219258A patent/JP6633170B2/ja active Active
-
2021
- 2021-06-01 CY CY20211100473T patent/CY1124191T1/el unknown
- 2021-06-04 HR HRP20210891TT patent/HRP20210891T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202012656WA (en) | Heterocyclic compounds useful in the treatment of disease | |
| IL285843A (en) | Ibrutinib for use in the treatment of graft-versus-host disease | |
| HK1258014A1 (zh) | 含前列腺酰胺的眼內植入物及其使用方法 | |
| HK1222530A1 (zh) | 用於皮膚處理的微閉合及相關方法 | |
| IL243599A0 (en) | surgical implant | |
| IL240398A0 (en) | surgical implant | |
| IL240349B (en) | surgical implant | |
| IL240534A0 (en) | surgical implant | |
| EP2950749A4 (en) | EXPANDER TO IMPLANT IN HUMAN TISSUE | |
| EP2890440A4 (en) | DEVICES AND METHOD FOR THE TREATMENT OF VASCULAR DISEASES | |
| EP2958936A4 (en) | METHOD AND COMPOSITIONS FOR TREATING CORI DISEASE | |
| EP2967876A4 (en) | REMOVABLE REINFORCEMENT FOR A MEDICAL IMPLANT | |
| HK1216833A1 (zh) | 組織擴張器、移植物及使用方法 | |
| PL3073936T3 (pl) | Wszczep medyczny | |
| LT2958624T (lt) | Transplantuotų pacientų transplantanto prieš šeiminiką ligos gydymas | |
| HK1204452A1 (en) | Treatment for bone diseases | |
| EP2968452A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF NETWORK DISEASES | |
| HRP20190041T1 (hr) | Usatci za poticanje integriranja mekog i tvrdog tkiva | |
| GB201421052D0 (en) | Artificial tissue | |
| EP3046629A4 (en) | Treatment of inflammatory skin disease | |
| GB201321628D0 (en) | Treatment of disease | |
| IL240226A0 (en) | Implantable tissue expanders for humans | |
| GB201320014D0 (en) | Treatment of cardiovascular disease | |
| GB201204645D0 (en) | Treatment of disease |